Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis.
暂无分享,去创建一个
V. Chopra | K. Eagle | S. Saint | J. Sussman | M. Rogers | J. Froehlich | Todd M. Greene | David H. Wesorick
[1] K. Channon,et al. Preoperative Atorvastatin Treatment in CABG Patients Rapidly Improves Vein Graft Redox State by Inhibition of Rac1 and NADPH-Oxidase Activity , 2010, Circulation.
[2] J. Kluger,et al. Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. , 2010, The Journal of thoracic and cardiovascular surgery.
[3] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[4] J. Liao,et al. Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[5] Jeroen J. Bax,et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. , 2009, The New England journal of medicine.
[6] H. Calkins,et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. , 2009, Journal of the American College of Cardiology.
[7] Malte Kelm,et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. , 2009, European heart journal.
[8] Y. Mei,et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[9] H. Takagi,et al. A meta-analysis of controlled studies of preoperative statin therapy for prevention of postoperative mortality in cardiac surgery. , 2009, The Journal of thoracic and cardiovascular surgery.
[10] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[11] Jeroen J. Bax,et al. Medication Underuse During Long-Term Follow-Up in Patients With Peripheral Arterial Disease , 2009, Circulation. Cardiovascular quality and outcomes.
[12] Shaghayegh Haghjooy Javanmard,et al. l-Arginine supplementation enhances eNOS expression in experimental model of hypercholesterolemic rabbits aorta. , 2009, Pathophysiology : the official journal of the International Society for Pathophysiology.
[13] Jeroen J. Bax,et al. Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Noncardiovascular Surgery: A Randomized Controlled Trial (DECREASE-IV) , 2009, Annals of surgery.
[14] M. Yılmaz,et al. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. , 2009, The Thoracic and cardiovascular surgeon.
[15] P. Shah,et al. Inflammation and Plaque Vulnerability , 2009, Cardiovascular Drugs and Therapy.
[16] F. Musumeci,et al. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. , 2008, The Journal of thoracic and cardiovascular surgery.
[17] G. Wassmer,et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. , 2008, European heart journal.
[18] Y. On,et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. , 2008, American heart journal.
[19] C. Muñoz,et al. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. , 2008, European cytokine network.
[20] Denis Xavier,et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.
[21] Tong Liu,et al. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. , 2008, International journal of cardiology.
[22] F. Álvarez,et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. , 2008, The Journal of cardiovascular surgery.
[23] Thomas E. Moritz,et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. , 2008, European heart journal.
[24] B. Heniford,et al. Postoperative pulmonary embolism: timing, diagnosis, treatment, and outcomes. , 2007, American journal of surgery.
[25] Jeroen J. Bax,et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. , 2007, The American journal of cardiology.
[26] B. Riedel,et al. Improved Postoperative Outcomes Associated with Preoperative Statin Therapy , 2006, Anesthesiology.
[27] Jeanette Buckingham,et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies , 2006, BMJ : British Medical Journal.
[28] V. Pasceri,et al. Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study , 2006, Circulation.
[29] D. Spevack,et al. Effects of statins beyond lipid lowering: potential for clinical benefits. , 2006, International journal of cardiology.
[30] F. Agrò,et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery , 2006, Critical care medicine.
[31] Jeroen J. Bax,et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. , 2005, American Journal of Cardiology.
[32] Belinda Young,et al. Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. , 2003, The American journal of medicine.
[33] Marlene R. Miller,et al. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. , 2003, JAMA.
[34] N J Wald,et al. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.
[35] M. Ezekowitz,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.
[36] B. Hoogwerf,et al. Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial , 2000 .
[37] P. Mills,et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. , 2000, Circulation.
[38] E F Cook,et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.
[39] Mylan C. Cohen,et al. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[40] J. Christenson. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[41] Teresa C. Horan,et al. Guideline for Prevention of Surgical Site Infection, 1999 , 1999, Infection Control & Hospital Epidemiology.
[42] J B Atkinson,et al. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. , 1996, International journal of cardiology.
[43] W. Browner,et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. , 1996, JAMA.
[44] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[45] Y. Mei,et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. , 2011, International heart journal.
[46] G. Moneta. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2009 .
[47] B. Caramelli,et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial , 2006 .